Lexology February 5, 2021
On January 15, 2021, the Centers for Medicare & Medicaid Services (“CMS”) issued the Contract Year 2022 Medicare Advantage and Part D Final Rule. The final rule was released amidst a flurry of regulations and program updates that the Trump administration’s Department of Health and Human Services issued in its final days, and includes a number of measures that touch on access to care, price transparency, and competition, including measures that:
- Allow for Part D formularies to include two specialty tiers;
- Require Part D plans to implement a drug benefit tool that gives beneficiaries and providers real-time information on out-of-pocket costs for prescription drugs;
- Require Medicare Part D plans to report to CMS the measures that plans use to...